Log In
Print
BCIQ
Print
Print this Print this
 

Aminoacyl tRNA synthetase fragments (Tmax) (ATYR0030)

  Manage Alerts
Collapse Summary General Information
Company aTyr Pharma Inc.
DescriptionRecombinant form of a signaling peptide derived from human aminoacyl tRNA synthetases
Molecular Target
Mechanism of Action 
Therapeutic ModalityPeptide
Latest Stage of DevelopmentPreclinical
Standard IndicationNeuropathy
Indication DetailsTreat neuropathy
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today